Why the study?
To describe the clinical phenotypes, diagnostic test results, and differences by age, sex, and troponin elevation in COVID-19 vaccine-associated myocarditis.
What are the clinical phenotypes and diagnostic test results of COVID-19 vaccine-associated myocarditis?
What are the clinical phenotypes and diagnostic test results of COVID-19 vaccine-associated myocarditis?
COVID-19 vaccine-associated myocarditis is generally mild, predominantly affects young males after the second mRNA dose, and a threefold troponin increase may serve as a threshold for risk stratification.
No takes yet. Share an insight, caveat, or question.
Supports troponin threefold threshold to guide cMRI; leaves open prospective validation of risk stratification.
Smith et al. (2024) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: